170 related articles for article (PubMed ID: 6754609)
1. Methylprednisolone inhibits the alternative and amplification pathways of complement.
Weiler JM; Packard BD
Infect Immun; 1982 Oct; 38(1):122-6. PubMed ID: 6754609
[TBL] [Abstract][Full Text] [Related]
2. Steroids inhibit activation of the alternative-amplification pathway of complement.
Packard BD; Weiler JM
Infect Immun; 1983 Jun; 40(3):1011-4. PubMed ID: 6343236
[TBL] [Abstract][Full Text] [Related]
3. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
[TBL] [Abstract][Full Text] [Related]
4. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of alternative pathway factor D by factor B-related synthetic hexapeptides.
Lesavre P; Gaillard MH; Halbwachs-Mecarelli L
Eur J Immunol; 1982 Mar; 12(3):252-4. PubMed ID: 6920299
[TBL] [Abstract][Full Text] [Related]
6. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
Joiner K; Sher A; Gaither T; Hammer C
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the alternative complement pathway and proteases of the coagulation system.
Kazatchkine MD; Jouvin MH
Adv Exp Med Biol; 1984; 167():235-9. PubMed ID: 6561912
[No Abstract] [Full Text] [Related]
8. Volcanic ash and human complement.
Olenchock SA; Mull JC
Life Sci; 1981 Feb; 28(7):791-4. PubMed ID: 6262591
[No Abstract] [Full Text] [Related]
9. Effects of lysine and glutamic acid or [corrected] Mg++ on the conformations of C3 and B, and the activation of the alternative complement pathway.
Takada A; Takada Y; Makino Y; Sugawara Y; Shirahama S
Complement; 1987; 4(2):110-9. PubMed ID: 2887399
[TBL] [Abstract][Full Text] [Related]
10. Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway.
Kings M; Nydegger UE; de Weck AL
Immunology; 1984 Jan; 51(1):123-31. PubMed ID: 6197357
[TBL] [Abstract][Full Text] [Related]
11. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
DiScipio RG
Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
[TBL] [Abstract][Full Text] [Related]
13. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
Jimenez-Lucho VE; Joiner KA; Foulds J; Frank MM; Leive L
J Immunol; 1987 Aug; 139(4):1253-9. PubMed ID: 2440949
[TBL] [Abstract][Full Text] [Related]
14. Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.
Volokhina EB; Westra D; van der Velden TJ; van de Kar NC; Mollnes TE; van den Heuvel LP
Clin Exp Immunol; 2015 Aug; 181(2):306-13. PubMed ID: 25079699
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the formation of the human amplification C3 convertase of complement by polycations.
Maillet F; Kazatchkine MD
Immunology; 1983 Sep; 50(1):27-33. PubMed ID: 6554235
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a 33,000-dalton fragment of complement Factor B with catalytic and C3b binding activity.
Lambris JD; Müller-Eberhard HJ
J Biol Chem; 1984 Oct; 259(20):12685-90. PubMed ID: 6567645
[TBL] [Abstract][Full Text] [Related]
17. Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome.
Schein RM; Bergman R; Marcial EH; Schultz D; Duncan RC; Arnold PI; Sprung CL
Chest; 1987 Jun; 91(6):850-4. PubMed ID: 3556054
[TBL] [Abstract][Full Text] [Related]
18. The activation of the alternative pathway C3 convertase by human plasma kallikrein.
DiScipio RG
Immunology; 1982 Mar; 45(3):587-95. PubMed ID: 6916710
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
[TBL] [Abstract][Full Text] [Related]
20. Species specificity of recognition by the alternative pathway of complement.
Horstmann RD; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1985 Feb; 134(2):1101-4. PubMed ID: 3155536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
